FDA approves novel non-uranium Mo-99 production process
The US Food and Drug Administration has approved NorthStar Medical Radioisotopes, LLC's process to produce molybdenum-99 from concentrated Mo-98 and related software upgrades for its RadioGenix System technetium-99m generator. This will significantly increase US production and capacity for non-uranium based Mo-99, the company says.
(Photo credit: NorthStar - https://www.northstarnm.com)